Descripción Del Producto

2-FMA Capsules 50mg

2-FMA Capsules 50mg is a synthetic substituted amphetamine and novel psychoactive substance (NPS) belonging to the fluorinated amphetamine class. It is No aprobado para uso médico. anywhere in the world and is sold strictly as a research chemical. A 50mg capsule is generally considered a strong or heavy dose based on user reports.

Farmacología

2-FMA primarily acts as a dopamine and norepinephrine reuptake inhibitor and releasing agent. It has significantly lower serotonergic activity compared to 4-FMA or MDMA. This profile leads to more “functional” stimulant effects — increased focus, motivation, and energy — with reduced empathogenic/entactogenic qualities.

Onset: 20–60 minutes (oral) Peak: 2–5 hours Duration: 6–10 hours (including after-effects)

It is structurally related to methamphetamine and 2-FA, with the fluorine atom at the 2-position of the phenyl ring increasing metabolic stability.

Perfil de seguridad aguda

• Cardiovascular Risks: Like other amphetamines, 2-FMA can increase heart rate, blood pressure, and body temperature. At 50mg, these effects can be pronounced and may pose risks for individuals with hypertension, heart conditions, or arrhythmia.
• Neurological Effects: Common side effects include jitteriness, anxiety, insomnia, appetite suppression, and jaw clenching. Higher doses increase the likelihood of overstimulation, paranoia, or panic.
• Neurotoxicidad: Fluorinated amphetamines have been associated with potential dopaminergic neurotoxicity in animal studies, though human data is extremely limited. Long-term or frequent use may carry risks to brain health.

Posibles efectos adversos

• Short-term: Dry mouth, headache, muscle tension, elevated body temperature, difficulty sleeping.
• Psychological: Anxiety, irritability, mood crashes during comedown, and potential for compulsive redosing.
• Rare/Severe: Hyperthermia, seizures, cardiovascular events, or serotonin syndrome (especially when mixed with other substances).

Interacciones farmacológicas y contraindicaciones

• Alto riesgo: MAOIs, other stimulants, SSRIs (possible serotonin syndrome), and alcohol.
• Precaución: Caffeine, cannabis, or any medications affecting blood pressure or heart rate.
• Strongly contraindicated for people with cardiovascular disease, glaucoma, hyperthyroidism, anxiety disorders, or history of stimulant misuse.

Product-Related Risks

As an unregulated research chemical:

• Capsules may have inconsistent dosing or purity.
• Unknown long-term toxicity profile.
• Potential presence of synthesis byproducts or other contaminants.

Estatus legal (a partir de 2026)

2-FMA is controlled or banned in many countries (e.g., USA under analogue laws if intended for human consumption, UK, Germany, Australia, Canada, and others). It remains in a gray area in some jurisdictions but is generally considered illegal for human consumption.

Nota importante: This is a neutral, educational overview based on available scientific literature and user-reported data. There are no clinical safety studies on 2-FMA in humans. Significant uncertainties exist regarding both short-term and long-term risks. This information does no encourage use. Consult a qualified healthcare professional for any health-related concerns and comply with all local laws. Stimulant research chemicals carry real potential for harm, dependence, and cardiovascular complications.

Información Adicional